Case Studies for New
AFib Patient Acquisition
Case Studies for New AFib Patient Acquisition
Case Studies for New
AFib Patient Acquisition
Case Studies for New
AFib Patient Acquisition
Case Studies for New AFib Patient Acquisition
Case Study #1:
Commercial AFib Therapies
Case Study #1:
Commercial AFib Therapies
Case Study #1:
Commercial AFib Therapies
To accelerate new patient acquisition for its growing AFib service line, Northwestern Medicine implemented our turn-key platform in 2018. Just 100 days after launch, Northwestern Medicine received 30 new pre-screened patients and stated, “This is a lot of new patient activity!”
To accelerate new patient acquisition for its growing AFib service line, Northwestern Medicine implemented our turn-key platform in 2018. Just 100 days after launch, Northwestern Medicine received 30 new pre-screened patients and stated, “This is a lot of new patient activity!”
To accelerate new patient acquisition for its growing AFib service line, Northwestern Medicine implemented our turn-key platform in 2018. Just 100 days after launch, Northwestern Medicine received 30 new pre-screened patients and stated, “This is a lot of new patient activity!”
To accelerate new patient acquisition for its growing AFib service line, Northwestern Medicine implemented our turn-key platform in 2018. Just 100 days after launch, Northwestern Medicine received 30 new pre-screened patients and stated, “This is a lot of new patient activity!”
Case Study #2:
AFib Clinical Trials
Case Study #2:
AFib Clinical Trials
Case Study #2:
AFib Clinical Trials
Case Study #2:
AFib Clinical Trials
AtriCure, Inc. (NASDAQ: ATRC), a leading provider of radiofrequency and cryoablation technologies, implemented our high-velocity patient recruitment platform for an AFib clinical trial that was struggling with patient enrollment. Just 90-days after implementation, AtriCure received 111 pre-screened patients and stated, “This technology has transformed AtriCure’s approach to clinical trial patient recruitment.”
AtriCure, Inc. (NASDAQ: ATRC), a leading provider of radiofrequency and cryoablation technologies, implemented our high-velocity patient recruitment platform for an AFib clinical trial that was struggling with patient enrollment. Just 90-days after implementation, AtriCure received 111 pre-screened patients and stated, “This technology has transformed AtriCure’s approach to clinical trial patient recruitment.”
AtriCure, Inc. (NASDAQ: ATRC), a leading provider of radiofrequency and cryoablation technologies, implemented our high-velocity patient recruitment platform for an AFib clinical trial that was struggling with patient enrollment. Just 90-days after implementation, AtriCure received 111 pre-screened patients and stated, “This technology has transformed AtriCure’s approach to clinical trial patient recruitment.”
AtriCure, Inc. (NASDAQ: ATRC), a leading provider of radiofrequency and cryoablation technologies, implemented our high-velocity patient recruitment platform for an AFib clinical trial that was struggling with patient enrollment. Just 90-days after implementation, AtriCure received 111 pre-screened patients and stated, “This technology has transformed AtriCure’s approach to clinical trial patient recruitment.”
